Deworming Medications for Children
For soil-transmitted helminth infections in children, albendazole 400 mg as a single oral dose is the first-line treatment for children aged >24 months, with ivermectin 200 μg/kg added for enhanced efficacy against Trichuris and Strongyloides. 1
Standard Dosing Regimens
Albendazole (First-Line)
- Children >24 months: 400 mg single oral dose 1
- Children 12-24 months: Discuss with expert before treatment 1
- Repeat dosing: Consider repeating at 2 weeks for certain infections (e.g., Enterobius, Echinococcus) 1
Combination Therapy for Enhanced Efficacy
- Albendazole 400 mg PLUS Ivermectin 200 μg/kg (single doses) for:
Critical caveat: Exclude Loa loa infection before administering ivermectin in children who have traveled to endemic regions (Central/West Africa), as ivermectin can cause severe adverse reactions in loiasis 1
Alternative Agents
Mebendazole
- Dosing: 500 mg single dose OR 100 mg twice daily for 3 days 1
- Efficacy: Comparable to albendazole for Ascaris lumbricoides (98.69% egg reduction rate) but suboptimal for Trichuris (48.15% cure rate) and hookworm (49.32% cure rate) 3
Praziquantel (for Schistosomiasis)
- Dosing: 25 mg/kg three times daily for 2-3 consecutive days 1
- Timing: For acute schistosomiasis, repeat treatment at 8 weeks to treat residual worms after maturation 1
Helminth-Specific Considerations
Ascaris lumbricoides
- Single-dose albendazole achieves 80.1% cure rate and 70.8% egg reduction rate 2
- Both albendazole and mebendazole show >95% egg reduction rates 3
Trichuris trichiura
- Major treatment challenge: Single-dose albendazole shows only 27.1% cure rate 2
- Solution: Albendazole + ivermectin combination increases cure rate to 75.2% with 84.2% egg reduction 2
- Mebendazole alone similarly suboptimal (48.15% cure rate) 3
Hookworm Species
- Albendazole preferred: 93.44% egg reduction rate and 78.32% cure rate 3
- Mebendazole less effective: 49.32% cure rate 3
Strongyloides stercoralis
- Ivermectin 200 μg/kg is the treatment of choice 1
- Can be combined with albendazole for empirical treatment 1
Important Clinical Pitfalls
Reinfection Rates
- Critical limitation: In endemic areas, reinfection occurs rapidly—Ascaris infections return to baseline levels by 12-16 weeks post-treatment 4
- This explains why mass deworming programs show minimal long-term nutritional or developmental benefits 5
Treatment Failure Recognition
- Persistent symptoms or eosinophilia 2-4 weeks post-treatment suggests:
Schistosomiasis Timing
- Eggs and immature schistosomulae are resistant to praziquantel 1
- Must repeat treatment at 8 weeks to target mature worms 1
Mass Deworming Programs vs Individual Treatment
Individual Treatment (Known Infection)
- Children with confirmed helminth infection may gain 0.2-1.3 kg additional weight over 1-6 months with treatment 5
- Justifies treatment in symptomatic or heavily infected children 5
Community Mass Deworming
- Evidence shows minimal benefit: No significant effect on average weight gain (0.04 kg difference), hemoglobin, cognition, school performance, or mortality in endemic area programs 5
- WHO still recommends biannual treatment in high-prevalence areas for morbidity reduction, despite limited evidence for broader health benefits 5
Special Populations
HIV-Infected Children
- Same dosing regimens apply 1
- Consider empirical treatment for eosinophilia, as helminth co-infection is common 1